Larimar Therapeutics, Inc. (LRMR)
NASDAQ: LRMR · Real-Time Price · USD
3.100
-0.070 (-2.21%)
Jun 8, 2026, 1:36 PM EDT - Market open
Larimar Therapeutics Market Cap
Larimar Therapeutics has a market cap or net worth of $323.59 million as of June 8, 2026. Its market cap has increased by 161.86% in one year.
Market Cap
323.59M
Enterprise Value
134.29M
1-Year Change
161.86%
Ranking
Category
Stock Price
$3.10
Market Cap Chart
Since May 29, 2020, Larimar Therapeutics's market cap has increased from $113.38M to $323.59M, an increase of 185.40%. That is a compound annual growth rate of 19.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 5, 2026 | 330.89M | 1.47% |
| Dec 31, 2025 | 326.10M | 32.06% |
| Dec 31, 2024 | 246.93M | 23.61% |
| Dec 29, 2023 | 199.77M | 11.79% |
| Dec 30, 2022 | 178.70M | -6.49% |
| Dec 31, 2021 | 191.10M | -41.88% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| May 29, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Puma Biotechnology | 357.82M |
| Shattuck Labs | 351.20M |
| Lexeo Therapeutics | 343.14M |
| Atea Pharmaceuticals | 340.12M |
| Artiva Biotherapeutics | 332.83M |
| Enanta Pharmaceuticals | 328.00M |
| Greenwich LifeSciences | 326.59M |
| Verastem | 326.01M |